Compare ARQT & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | HWKN |
|---|---|---|
| Founded | 2016 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2020 | N/A |
| Metric | ARQT | HWKN |
|---|---|---|
| Price | $25.38 | $131.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $25.00 | ★ $200.00 |
| AVG Volume (30 Days) | ★ 1.5M | 158.3K |
| Earning Date | 02-25-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | N/A | ★ 1.06 |
| EPS | N/A | ★ 3.95 |
| Revenue | $317,929,000.00 | ★ $1,063,104,000.00 |
| Revenue This Year | $85.83 | $14.22 |
| Revenue Next Year | $30.72 | $7.46 |
| P/E Ratio | ★ N/A | $32.98 |
| Revenue Growth | ★ 129.21 | 11.65 |
| 52 Week Low | $11.13 | $98.30 |
| 52 Week High | $31.77 | $186.15 |
| Indicator | ARQT | HWKN |
|---|---|---|
| Relative Strength Index (RSI) | 37.28 | 28.60 |
| Support Level | $25.51 | $148.09 |
| Resistance Level | $26.97 | $154.87 |
| Average True Range (ATR) | 1.08 | 5.74 |
| MACD | -0.15 | -2.43 |
| Stochastic Oscillator | 12.10 | 1.05 |
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.